What To Prioritize When Selecting A Phase 1 CRO
Source: Life Science Leader
By Industry Standard Research
A critical factor when examining service provider selection is the existence of preferred provider agreements. Keeping this in mind, ISR asks respondents to share their selection criteria in a way that demonstrates these agreements’ impacts on the decision-making process. Three attributes are prevalent in all three scenarios: Operational Excellence, Therapeutic Excellence, and Access To Patient Populations.
This website uses cookies to ensure you get the best experience on our website. Learn more